Rubin Jonathan (CIK 1836067) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-14). Recent activity: Buy SUPN (750 shares), Sell SUPN (363 shares), Buy SUPN (1,250 shares), Sell SUPN (675 shares), Buy SUPN (1,125 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-14 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | Buy | 750 | $0 |
| 2026-08-14 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | Sell | 363 | $16,905 |
| 2026-02-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | Buy | 1,250 | $0 |
| 2026-02-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | Sell | 675 | $34,216 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | Buy | 1,125 | $0 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | Sell | 603 | $30,964 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | Buy | 750 | $0 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | Sell | 369 | $18,767 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | Buy | 1,250 | $0 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | Sell | 671 | $0 |
| 2025-09-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | Buy | 1,875 | $0 |
| 2025-09-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | Sell | 840 | $38,816 |
来源：SEC Form 4 申报文件 · 截至 2026-08-14